651 related articles for article (PubMed ID: 18368636)
1. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004.
Malila N; Anttila A; Hakama M
J Med Screen; 2005; 12(1):28-32. PubMed ID: 15814016
[TBL] [Abstract][Full Text] [Related]
3. Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland.
Malila N; Palva T; Malminiemi O; Paimela H; Anttila A; Hakulinen T; Järvinen H; Kotisaari ML; Pikkarainen P; Rautalahti M; Sankila R; Vertio H; Hakama M
J Med Screen; 2011; 18(1):18-23. PubMed ID: 21536812
[TBL] [Abstract][Full Text] [Related]
4. Colorectal screening in Germany.
Pox C; Schmiegel W
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S31-2. PubMed ID: 18368638
[No Abstract] [Full Text] [Related]
5. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer screening in the Czech Republic.
Zavoral M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S29-30. PubMed ID: 18368637
[TBL] [Abstract][Full Text] [Related]
7. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
[TBL] [Abstract][Full Text] [Related]
8. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
Malila N; Hakama M; Pukkala E
Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
[TBL] [Abstract][Full Text] [Related]
9. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
[TBL] [Abstract][Full Text] [Related]
11. Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK
Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
[TBL] [Abstract][Full Text] [Related]
12. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
13. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
[TBL] [Abstract][Full Text] [Related]
14. French colorectal cancer screening pilot programme: results of the first round.
Goulard H; Boussac-Zarebska M; Ancelle-Park R; Bloch J
J Med Screen; 2008; 15(3):143-8. PubMed ID: 18927097
[TBL] [Abstract][Full Text] [Related]
15. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
[TBL] [Abstract][Full Text] [Related]
16. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
17. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M
Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750
[TBL] [Abstract][Full Text] [Related]
18. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.
Segnan N; Senore C; Andreoni B; Azzoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; Ederle A; Fantin A; Ferrari A; Fracchia M; Ferrero F; Gasperoni S; Recchia S; Risio M; Rubeca T; Saracco G; Zappa M;
Gastroenterology; 2007 Jun; 132(7):2304-12. PubMed ID: 17570205
[TBL] [Abstract][Full Text] [Related]
19. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
Kronborg O; Jørgensen OD; Fenger C; Rasmussen M
Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
[TBL] [Abstract][Full Text] [Related]
20. Mass screening for colorectal cancer: compliance in Almopea Region.
Chrissidis T; Saliangas K; Economou A; Nikoloudis N; Andreadis E; Prodromou K; Georgakis K
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s193-5. PubMed ID: 15655620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
